The stock of Zoetis Inc. (NYSE:ZTS) increased by $1.26 on Friday to finish at $182.82, up 0.69 percent. The last five days have seen an average of 1,051,880 shares of common stock traded. 21 times new highs were reached in the current year, with a gain of $36.27. The average number of shares traded over the last 20 days was 1,714,990, while the average volume over the last 50 days totaled 1,906,430.
ZTS stock dropped -3.11% since last month. On 08/08/23, the company’s shares reached a one-month low of $177.25. The stock touched a high of $194.99 on 07/27/23, after rallying from a low of $124.15 in 52 weeks. The price of ZTS stock has risen by 24.75% or $36.27 this year, reaching a new high 21 times. Still, the stock price is down -6.24% from the 52-week high.
Insider Transactions
ZTS stock investors should be aware that Zoetis Inc. (ZTS) stock had its last reported insider trading activity 6 days ago on Aug 22. On Aug 22, Chief Executive Officer PECK KRISTIN C sold 13,000 shares at $179.97 each. This transaction resulted in the insider making $2,339,564. On Aug 09, Polzer Robert J sold 1,179 shares at a price of US$189.94. After the transaction, the insider now owns 2,353 shares. Chief Executive Officer PECK KRISTIN C had earlier sold 13,000 shares on May 23 for $176.56 a share. The transaction was completed for $2,295,335.
Valuation Metrics
Zoetis Inc. (ZTS) has a trailing price-to-earnings (P/E) ratio of 38.45. Beta for the stock is 0.78. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 10.16, the price-to-book (PB) ratio of 18.26, and the price-to-cash flow ratio of 65.04.
Company paid $0.3750 per share in dividends, remained unchanged from $0.3750 last year. A $0.05 dividend increase was reported on Thursday December 8 2022.
Financial Health
For the three months ended June 29, Zoetis Inc.’s quick ratio was 2.00, while its current ratio was 3.50, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 1.42, and the total debt to equity ratio is 1.42. As far as profitability goes, gross margin for the trailing twelve months is 70.60% percent. Zoetis Inc.’s EBITDA margin for the year ended June 29 was 41.99%, whereas its operating margin stood at 34.40% for the same period. Based on annual data, it had gross profit of $5.63 billion and revenue of $8.08 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. ZTS’s return on assets (ROA) during the last 12 months has been 15.80%. There was a 17.20% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 48.70%.
Earnings Surprise
According to Zoetis Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $2.18 billion, while revenues rose by 5.87% to $2.0 billion. It was predicted that Zoetis Inc.’s quarterly earnings would be $1.41, but it ended up being $1.31, beating the consensus by 7.60%. EBITDA was $1.05 billion for the quarter. At the end of Zoetis Inc.’s most recent quarter ended June 29, its liabilities totaled 9.13 billion, while its total debt was $6.78 billion. Equity owned by shareholders amounts to $460.32 million.
Technical Picture
Here’s a quick look at Zoetis Inc.’s (ZTS) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 47.30%, suggesting the stock is Neutral, with a 16.27% historical volatility rate.
The stochastic %K and %D were 36.86% and 34.86% respectively, while the average true range (ATR) was 3.77. Based on the 14-day stochastic reading of 36.49%, the RSI (14) reading is 50.28%. On the 9-day MACD Oscillator, the stock is at -0.57, and the 14-day reading is at -2.78.
Analyst Ratings
In its analyst report released on July 12, 2022, Piper Sandler began covering Zoetis Inc. (NYSE: ZTS). The stock was rated as an Overweight by the brokerage firm. Analysts have assigned Zoetis Inc. (ZTS) an Buy rating. ZTS is a stock that is recommended for selling by 0 brokerage firms, while 2 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 11 others recommend it as a buy.
What is ZTS’s price target for the next 12 months?
The current consensus forecast for the stock is between $190.00 and $260.00, with a median target price of $220.00. In analyzing these forecasts, the average price target given by analysts for Zoetis Inc. (ZTS) is $221.91.
